News in 2019

Czech version

Authors: Lukáš M.
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a. s., Praha
Published in: Gastroent Hepatol 2019; 73(1): 5
Category: Editorial

Labels

Paediatric gastroenterology Gastroenterology and hepatology Surgery

Biologics for inflammatory bowel disease – forth time

Inflammatory bowel disease and medical assessment service

Treatment of a pregnant Crohn’s disease patient with ustekinumab: a case report

Surprising etiology of terminal common bile duct stricture

Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux

Does abdominal compression improve the success rate of and tolerance to colonoscopy?

Toxic and drug damage of the liver and kidneys

The selection from international journals

Clensia® – the first combined cleansing agent with simeticone

Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice

Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel disease

Ileocaecal Crohn’s disease and familial adenomatous polyposis in one patient – a case report

First European Conference of Young Gastroenterologists – ECYG

Article was published in

Gastroenterology and Hepatology

2019 Issue 1